Liver Regeneration is a remarkable biological process through which the liver can repair and restore its functional capacity following injury or partial loss. The liver is known for its unique regenerative ability, facilitated by the proliferation of existing hepatocytes, the primary functional cells of the liver. In response to injury or surgical removal, quiescent hepatocytes are stimulated to enter the cell cycle, undergoing rapid division to replace damaged tissue. The regenerative process is tightly regulated by a complex interplay of growth factors, cytokines, and signaling pathways, with hepatocyte growth factor (HGF) and epidermal growth factor (EGF) being pivotal players. In addition to hepatocyte proliferation, liver regeneration involves the activation of hepatic progenitor cells, which can differentiate into mature liver cells. While the liver's regenerative capacity is impressive, chronic injury or disease may lead to impaired regeneration and the development of fibrosis or cirrhosis. Understanding the mechanisms underlying liver regeneration holds significant clinical relevance, with implications for liver transplantation, the treatment of liver diseases, and the development of regenerative medicine strategies. Ongoing research seeks to uncover the molecular and cellular cues governing liver regeneration, paving the way for innovative therapeutic interventions and approaches to enhance liver repair and function.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States